BRISTOL-MYERS SQUIBB CO (BMY) Stock Fundamental Analysis

NYSE:BMY • US1101221083

60.74 USD
+0.88 (+1.47%)
At close: Feb 13, 2026
60.45 USD
-0.29 (-0.48%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, BMY scores 6 out of 10 in our fundamental rating. BMY was compared to 191 industry peers in the Pharmaceuticals industry. BMY scores excellent on profitability, but there are some minor concerns on its financial health. BMY is cheap, but on the other hand it scores bad on growth. BMY also has an excellent dividend rating. This makes BMY very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • BMY had positive earnings in the past year.
  • BMY had a positive operating cash flow in the past year.
  • Of the past 5 years BMY 4 years were profitable.
  • Of the past 5 years BMY 4 years had a positive operating cash flow.
BMY Yearly Net Income VS EBIT VS OCF VS FCFBMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • BMY's Return On Assets of 6.23% is amongst the best of the industry. BMY outperforms 86.91% of its industry peers.
  • BMY's Return On Equity of 32.55% is amongst the best of the industry. BMY outperforms 94.76% of its industry peers.
  • The Return On Invested Capital of BMY (17.64%) is better than 95.29% of its industry peers.
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROIC 17.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMY Yearly ROA, ROE, ROICBMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • The Profit Margin of BMY (12.57%) is better than 84.82% of its industry peers.
  • In the last couple of years the Profit Margin of BMY has grown nicely.
  • BMY has a better Operating Margin (33.51%) than 95.29% of its industry peers.
  • BMY's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 73.15%, BMY belongs to the best of the industry, outperforming 80.63% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
Industry RankSector Rank
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
BMY Yearly Profit, Operating, Gross MarginsBMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BMY is creating value.
  • BMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMY Yearly Shares OutstandingBMY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
BMY Yearly Total Debt VS Total AssetsBMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 2.32 indicates that BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BMY has a better Altman-Z score (2.32) than 62.83% of its industry peers.
  • BMY has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as BMY would need 3.20 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.20, BMY belongs to the top of the industry, outperforming 88.48% of the companies in the same industry.
  • A Debt/Equity ratio of 2.41 is on the high side and indicates that BMY has dependencies on debt financing.
  • The Debt to Equity ratio of BMY (2.41) is worse than 79.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Altman-Z 2.32
ROIC/WACC2.03
WACC8.69%
BMY Yearly LT Debt VS Equity VS FCFBMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that BMY should not have too much problems paying its short term obligations.
  • BMY has a Current ratio of 1.27. This is in the lower half of the industry: BMY underperforms 77.49% of its industry peers.
  • A Quick Ratio of 1.17 indicates that BMY should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.17, BMY is not doing good in the industry: 75.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.17
BMY Yearly Current Assets VS Current LiabilitesBMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 439.47% over the past year.
  • The Earnings Per Share has been decreasing by -0.92% on average over the past years.
  • BMY shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
  • Measured over the past years, BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.54% on average per year.
  • BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.61% yearly.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.61%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BMY Yearly Revenue VS EstimatesBMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
BMY Yearly EPS VS EstimatesBMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.88 indicates a reasonable valuation of BMY.
  • Compared to the rest of the industry, the Price/Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 91.62% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BMY to the average of the S&P500 Index (27.97), we can say BMY is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.98, which indicates a very decent valuation of BMY.
  • Based on the Price/Forward Earnings ratio, BMY is valued cheaper than 88.48% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, BMY is valued rather cheaply.
Industry RankSector Rank
PE 9.88
Fwd PE 9.98
BMY Price Earnings VS Forward Price EarningsBMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 93.19% of the companies listed in the same industry.
  • BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BMY is cheaper than 94.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.08
EV/EBITDA 7.3
BMY Per share dataBMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • BMY has an outstanding profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as BMY's earnings are expected to decrease with -3.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • BMY has a Yearly Dividend Yield of 4.20%, which is a nice return.
  • BMY's Dividend Yield is rather good when compared to the industry average which is at 0.93. BMY pays more dividend than 96.86% of the companies in the same industry.
  • BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 4.2%

5.2 History

  • On average, the dividend of BMY grows each year by 11.67%, which is quite nice.
  • BMY has paid a dividend for at least 10 years, which is a reliable track record.
  • BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.67%
Div Incr Years3
Div Non Decr Years3
BMY Yearly Dividends per shareBMY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • BMY pays out 82.81% of its income as dividend. This is not a sustainable payout ratio.
  • BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP82.81%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
BMY Yearly Income VS Free CF VS DividendBMY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
BMY Dividend Payout.BMY Dividend Payout, showing the Payout Ratio.BMY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (2/13/2026, 8:04:00 PM)

After market: 60.45 -0.29 (-0.48%)

60.74

+0.88 (+1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners81.87%
Inst Owner Change-2.84%
Ins Owners0.02%
Ins Owner Change-1.11%
Market Cap123.65B
Revenue(TTM)48.19B
Net Income(TTM)6.04B
Analysts70.59
Price Target58.05 (-4.43%)
Short Float %1.82%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 4.2%
Yearly Dividend2.42
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)5.02%
PT rev (3m)10.23%
EPS NQ rev (1m)-32.94%
EPS NQ rev (3m)-32.35%
EPS NY rev (1m)-8.07%
EPS NY rev (3m)-7.12%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 9.88
Fwd PE 9.98
P/S 2.57
P/FCF 8.08
P/OCF 7.44
P/B 6.67
P/tB N/A
EV/EBITDA 7.3
EPS(TTM)6.15
EY10.13%
EPS(NY)6.09
Fwd EY10.02%
FCF(TTM)7.52
FCFY12.38%
OCF(TTM)8.16
OCFY13.44%
SpS23.6
BVpS9.11
TBVpS-11.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.51
Profitability
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROCE 23.41%
ROIC 17.64%
ROICexc 23.19%
ROICexgc 118.19%
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
FCFM 31.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Debt/EBITDA 2.13
Cap/Depr 26.84%
Cap/Sales 2.75%
Interest Coverage 7.66
Cash Conversion 79.11%
Profit Quality 253.39%
Current Ratio 1.27
Quick Ratio 1.17
Altman-Z 2.32
F-Score6
WACC8.69%
ROIC/WACC2.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.61%
EBIT growth 1Y44.7%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year13.96%
EBIT Next 3Y0.03%
EBIT Next 5Y-1.73%
FCF growth 1Y10.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.78%
OCF growth 3YN/A
OCF growth 5YN/A

BRISTOL-MYERS SQUIBB CO / BMY FAQ

What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BMY.


What is the valuation status for BMY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.


What is the profitability of BMY stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 8 / 10.


Can you provide the financial health for BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.


What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?

The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to decline by -1.05% in the next year.